Atara Biotherapeutics Earnings Calls

Q4 2024 (Upcoming)
Release date Mar 27, 2025
EPS estimate -$3.96
EPS actual -
Revenue estimate 17.065M
Revenue actual -
Expected change +/- 8.94%
Q3 2024 Beat
-$2.93 (22.28%)
Release date Nov 12, 2024
EPS estimate -$3.77
EPS actual -$2.93
EPS Surprise 22.28%
Revenue estimate 33.095M
Revenue actual 40.19M
Revenue Surprise 21.44%
Q2 2024 Missed
-$3.10 (-148.00%)
Release date Aug 12, 2024
EPS estimate -$1.25
EPS actual -$3.10
EPS Surprise -148.00%
Revenue estimate 39.99M
Revenue actual 28.64M
Revenue Surprise -28.38%
Q1 2024 Beat
-$5.75 (37.84%)
Release date May 09, 2024
EPS estimate -$9.25
EPS actual -$5.75
EPS Surprise 37.84%
Revenue estimate 24.69M
Revenue actual 27.357M
Revenue Surprise 10.80%

Last 4 Quarters for Atara Biotherapeutics

Below you can see how ATRA performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Q1 2024 Beat
Release date May 09, 2024
Fiscal end date Mar 31, 2024
Price on release $0.546
EPS estimate -$9.25
EPS actual -$5.75
EPS surprise 37.84%
Date Price
May 03, 2024 $0.670
May 06, 2024 $0.630
May 07, 2024 $0.603
May 08, 2024 $0.566
May 09, 2024 $0.546
May 10, 2024 $0.530
May 13, 2024 $0.556
May 14, 2024 $0.605
May 15, 2024 $0.640
4 days before -18.54%
4 days after 17.26%
On release day -2.91%
Change in period -4.48%
Q2 2024 Missed
Release date Aug 12, 2024
Fiscal end date Jun 30, 2024
Price on release $7.77
EPS estimate -$1.25
EPS actual -$3.10
EPS surprise -148.00%
Date Price
Aug 06, 2024 $8.27
Aug 07, 2024 $7.46
Aug 08, 2024 $7.67
Aug 09, 2024 $7.58
Aug 12, 2024 $7.77
Aug 13, 2024 $8.02
Aug 14, 2024 $7.72
Aug 15, 2024 $6.83
Aug 16, 2024 $7.01
4 days before -6.05%
4 days after -9.78%
On release day 3.22%
Change in period -15.24%
Q3 2024 Beat
Release date Nov 12, 2024
Fiscal end date Sep 30, 2024
Price on release $11.61
EPS estimate -$3.77
EPS actual -$2.93
EPS surprise 22.28%
Date Price
Nov 06, 2024 $10.01
Nov 07, 2024 $10.10
Nov 08, 2024 $11.31
Nov 11, 2024 $11.77
Nov 12, 2024 $11.61
Nov 13, 2024 $14.26
Nov 14, 2024 $12.77
Nov 15, 2024 $12.00
Nov 18, 2024 $11.33
4 days before 15.99%
4 days after -2.37%
On release day 22.88%
Change in period 13.24%
Q4 2024 (Upcoming)
Release date Mar 27, 2025
Fiscal end date Dec 30, 2024
Price on release -
EPS estimate -$3.96
EPS actual -
Date Price
Feb 06, 2025 $10.51
Feb 07, 2025 $9.92
Feb 10, 2025 $9.26
Feb 11, 2025 $8.42
Feb 12, 2025 $8.60

Atara Biotherapeutics Earnings History

Earnings Calendar

FAQ

When is the earnings report for ATRA?
Atara Biotherapeutics (ATRA) has scheduled its earnings report for Mar 27, 2025 before the markets open.

What is the ATRA price-to-earnings (P/E) ratio?
ATRA P/E ratio as of Feb 12, 2025 (TTM) is -0.0718.

What is the ATRA EPS forecast?
The forecasted EPS (Earnings Per Share) for Atara Biotherapeutics (ATRA) for the first fiscal quarter 2024 is -$3.96.

What are Atara Biotherapeutics's retained earnings?
On its balance sheet, Atara Biotherapeutics reported retained earnings of $40.19 million for the latest quarter ending Sep 30, 2024.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT ATARA BIOTHERAPEUTICS
Atara Biotherapeutics
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i...
GOLDEN STAR
Ticker Change Signal Date
LFUS
$234.72
3.32% Feb 10
ITW
$255.56
0.192% Feb 07
O
OBDC
$15.00
2.20% Feb 07
GGB
$2.95
2.37% Feb 06
BUD
$49.11
6.45% Feb 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE